Higher doses of oral semaglutide improves blood sugar control and weight loss

Diabetes is a progressive disease that affects one's ability to control blood sugar levels. For many patients, the condition becomes more severe over time and blood sugar levels grow more difficult to manage. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, have granted patients more control in lowering of blood sugar.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news